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Abstract
Background: Men who have sex with men (MSM) continue to be the predominately impacted risk group in the United States
HIV epidemic and are a priority group for risk reduction in national strategic goals for HIV prevention. Modeling studies have
demonstrated that a comprehensive package of status-tailored HIV prevention and care interventions have the potential to
substantially reduce new infections among MSM. However, uptake of basic prevention services, including HIV testing, sexually
transmitted infection (STI) testing, condom distribution, condom-compatible lubricant distribution, and preexposure prophylaxis
(PrEP), is suboptimal. Further, stronger public health strategies are needed to promote engagement in HIV care and viral load
suppression among MSM living with HIV. Mobile health (mHealth) tools can help inform and encourage MSM regarding HIV
prevention, care, and treatment, especially among men who lack access to conventional medical services. This protocol details
the design and procedures of a randomized controlled trial (RCT) of a novel mHealth intervention that comprises a comprehensive
HIV prevention app and brief, tailored text- and video-based messages that are systematically presented to participants based on
the participants’ HIV status and level of HIV acquisition risk.
Objective: The objective of the RCT was to test the efficacy of the Mobile Messaging for Men (M-Cubed, or M3) app among
at least 1200 MSM in Atlanta, Detroit, and New York. The goal was to determine its ability to increase HIV testing (HIV-negative
men), STI testing (all men), condom use for anal sex (all men), evaluation for PrEP eligibility, uptake of PrEP (higher risk
HIV-negative men), engagement in HIV care (men living with HIV), and uptake of and adherence to antiretroviral medications
(men living with HIV). A unique benefit of this approach is the HIV serostatus-inclusiveness of the intervention, which includes
both HIV-negative and HIV-positive MSM.
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Methods: MSM were recruited through online and venue-based approaches in Atlanta, Detroit, and New York City. Men who
were eligible and consented were randomized to the intervention (immediate access to the M3 app for a period of three months)
or to the waitlist-control (delayed access) group. Outcomes were evaluated immediately postintervention or control period, and
again three and six months after the intervention period. Main outcomes will be reported as period prevalence ratios or hazards,
depending on the outcome. Where appropriate, serostatus/risk-specific outcomes will be evaluated in relevant subgroups. Men
randomized to the control condition were offered the opportunity to use (and evaluate) the M3 app for a three-month period after
the final RCT outcome assessment.
Results: M3 enrollment began in January 2018 and concluded in November 2018. A total of 1229 MSM were enrolled. Data
collection was completed in September 2019.
Conclusions: This RCT of the M3 mobile app seeks to determine the effects of an HIV serostatus–inclusive intervention on
the use of multiple HIV prevention and care-related outcomes among MSM. A strength of the design is that it incorporates a
large sample and broad range of MSM with differing prevention needs in three cities with high prevalence of HIV among MSM.
Trial Registration: ClinicalTrials.gov NCT03666247; https://clinicaltrials.gov/ct2/show/NCT03666247
International Registered Report Identifier (IRRID): DERR1-10.2196/16439
(JMIR Res Protoc 2019;8(11):e16439) doi: 10.2196/16439
KEYWORDS
men who have sex with men; HIV prevention; HIV care

Introduction
Background
Men who have sex with men (MSM) face the highest burden
of HIV in the United States [1], and there is a paucity of
efficacious or promising mobile health (mHealth),
HIV-prevention interventions tailored specifically for MSM
[2]. New HIV prevention tools are needed that can address the
needs of MSM, especially young MSM aged 15-24 for whom
yearly HIV incidence doubled from 2002 to 2014 [3], and for
young MSM of color for whom these burdens are most severe
[4-6]. Currently, HIV prevention services are underutilized by
MSM, with just over half (56%) reporting being tested in the
past 12 months, high proportions (76% of HIV-positive and
66% of HIV-negative MSM) reporting recent condomless,
receptive anal intercourse, and few (<20%) reporting utilization
of pre-exposure prophylaxis (PrEP) [7]. Statistical models of
MSM epidemics parameterized to represent US epidemics
demonstrate that high levels of prevention service coverage will
be required to substantially reduce HIV incidence [8,9], and
increased utilization of routine prevention activities, like
frequent HIV testing, may enhance the uptake of biomedical
interventions like PrEP [10]. At the same time, engaging MSM
living with HIV in mHealth HIV-prevention efforts is critical
and addresses the two most important factors that determine
cost-effectiveness, namely the HIV prevalence of the target
population and the cost per person reached [11].
Researchers in the past decade have been exploring the most
effective ways to engage MSM in a package of HIV prevention
services. A growing body of research has suggested that mobile
phone apps provide a dynamic environment for intervention
and can offer on-demand prevention services for MSM [12-17].
This research indicates that MSM are open to receiving
prevention information and resources via apps [18]. Electronic
messages communicated through apps, known as mobile
messaging, are an appealing approach to enhance intervention
uptake because they allow for messaging that can reach a wide
http://www.researchprotocols.org/2019/11/e16439/
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audience of MSM, including rural MSM [16]. Further, younger
MSM might be especially interested in using mobile technology
to receive health information [19]. This study builds on an
existing HIV prevention app designed for MSM, HealthMindr,
to add and evaluate tailored prevention messaging.

The HealthMindr App
The HealthMindr app is a comprehensive HIV prevention app
for MSM [20]. Developed using social cognitive theory [20,21],
HealthMindr features basic prevention services, including:
screening for HIV and sexually transmitted infection (STI) risk;
a scheduling and reminder system for routine HIV testing; a
PrEP eligibility screener; a nonoccupational postexposure
prophylaxis (nPEP) risk assessment tool; an ordering platform
for delivery of at-home HIV and STI screening kits, condoms,
and lubricant; and service locators for HIV and STI testing, and
PrEP, nPEP, and HIV treatment and care. The app was built
based on extensive input from MSM, public health leaders, and
staff from community-based organizations [22,23]. The basic
app (before the addition of messages and videos) was pilot tested
with 121 MSM in Atlanta and Seattle, and the results indicated
high levels of acceptability, use of tools to develop and maintain
a consistent HIV testing routine, use of PrEP screening and
referrals, and ordering of at-home HIV test kits and condoms
[20].

Study Intervention: HealthMindr Plus Brief Messages
The current study utilized the HealthMindr platform with the
addition of social cognitive theory–based, sexual health
messaging components. For this randomized controlled trial
(RCT), we developed a series of brief text-based (n=63) and
sourced a series of video (n=12) messages designed designed
to promote health-seeking behavior and further the adoption of
sexual health services recommended by HealthMindr. The
messages were delivered through the HealthMindr platform and
aligned with the prevention tools offered in the app [20]. The
purpose of this study was to evaluate the use and efficacy of
the mobile-messaging platform as a public health strategy for
JMIR Res Protoc 2019 | vol. 8 | iss. 11 | e16439 | p. 2
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improving sexual health outcome measures among MSM by
determining whether exposure to the message-delivery platform
resulted in improvements in participants’ self-reported sexual
health and prevention behaviors, beliefs, and attitudes. Specific
aims to accomplish this purpose included two phases: (1)
formative research (focus groups and in-depth interviews) for
app message development; and (2) an RCT for testing efficacy
of the app. This paper describes the methods for this study in
more detail.

Methods
Overview
The Mobile Messaging for Men (M3) study was conducted in
two phases. The first phase consisted of a series of focus groups
and in-depth interviews to ensure that written messages, videos,
and app features presented in the trial were appropriate for the
audience. The second phase was an RCT, with MSM in three

Sullivan et al
serostatus/risk groups randomized to receive either the
intervention condition (M3 app) for a three-month exposure
period or a waitlist-control condition with the option to receive
the app for three months at the end of the study. The
serostatus/risk groups were defined by self-report as: (1) HIV
seropositive; (2) HIV seronegative at higher risk (condomless
anal sex and not taking PrEP as prescribed in the past 3 months);
and (3) HIV seronegative at lower risk (no condomless anal sex
in the past 3 months, or condomless anal sex while taking PrEP
as prescribed in the past 3 months). Postintervention data
collection occurred at three time points: 3 months (immediately
postintervention), 6 months (three-months postintervention),
and 9 months (six-months postintervention) (see Figure 1).
Participant follow-up will be completed in September 2019,
with primary outcome analyses to follow. The study was
reviewed and approved by the Emory University Institutional
Review Board (Protocol #87684) and registered at
ClinicalTrials.gov (NCT03666247).

Figure 1. Timeline of participant activities and assessments. Only participants from the waitlist/control group who opt to participate in the intervention
will be assessed in PT2. BL: baseline survey; PT: postintervention assessment; FU: follow-up survey.

Formative Research for Online Messages
Message Development Process
Message development for qualitative input from the target
audience took two forms: brief written message and video
message development. Two committees of subject matter experts
(written messages: JB, GM, PS, KH, MD, EO, RZ; video
messages: SH, MAC, EO, DG, BB, RZ, RS) were established
to implement written and video message creation. First, the
committees determined six domains of prevention messages
and related study outcomes: (1) condom use; (2) HIV testing;
(3) STI testing; (4) PrEP continuum outcomes; (5) antiretroviral
therapy (ART) use; and (6) engagement in care.
The written message committee reviewed the literature on HIV
prevention messages in the six domain areas, as well as
messages used in their ongoing research, and developed 63
messages that were 2-3 sentences each and were organized into
http://www.researchprotocols.org/2019/11/e16439/
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the 6 prevention domains. Messages within each domain were
mapped onto Social Cognitive Theory constructs (eg,
information, relevance, norms, barriers, and self-efficacy).
Through the mobile app, each participant received a common
core of 36 messages (approximately 6 messages per domain)
and another set of 9 secondary messages specific to each of the
3 serostatus/risk groups. For HIV-positive men, these secondary
messages focused on ART uptake and adherence, for
HIV-negative men who reported condomless anal sex in the
past three months, additional messages pertained to PrEP, and
for HIV-negative men who did not report recent condomless
anal sex, additional messages were about condom use and
HIV/STI testing. Participants were sent a written message every
1-2 days and a video message once per week.
The video messages were selected after identifying existing
videos in the field of recent HIV and STI prevention related to
the six domain areas, with the goal of identifying 12,
approximately one-minute video clips for delivery on the mobile
JMIR Res Protoc 2019 | vol. 8 | iss. 11 | e16439 | p. 3
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app. About two videos per domain area were delivered to all
study participants at a rate of one per week. Through online
searches and common, prevention video–development funding
agencies (eg, the Centers for Disease Control and Prevention
and the Kaiser Family Foundation), an initial pool of several
hundred videos was identified, and they were systematically
and iteratively reduced in number by the subject matter expert
committee through several rounds of reviews and ratings.

Phase 1: Formative Research
Qualitative Message Development Process
Two qualitative methods were used to elicit feedback from
MSM who were potential participants in the RCT: focus group
discussions and in-depth interviews. The goals of the qualitative
phase were to: (1) develop knowledge around possible topics
for HIV prevention messaging, preferred modes of receiving
mobile prevention messages, and messaging frequency; and (2)
develop HIV status/risk level-specific prevention messages
intended for dissemination to MSM, cognitively test the
messages, and finalize messages for inclusion in the RCT.
Nine focus group discussions, one per risk group per study city,
were conducted. Focus group discussions focused on message
delivery aspects, including mode, format, length, framing,
delivery source, and other non-content related characteristics.
Participants were prompted to describe notable HIV prevention
messages they had encountered prior to their engagement with
this study, describing both the content and format of the message
as well as their thoughts on its efficacy and applicability.
Participants were then asked to complete a pile-sorting activity
[24], where participants were shown cards with HIV prevention
messages and were asked to sort them into piles representing
how they would like those messages to be received (eg, a card
contained a message about regular condom use, and choices for
delivery of message included video, scientific facts, or fun
messaging). The aim was to understand which delivery and
content factors were important for the delivery of each type of
prevention message.
Two rounds of in-depth interviews were conducted: one round
for text-based messages and one round for video messages.
These in-depth interviews assessed the extent to which the

predeveloped text- or video-based messages were understood
and believed, and how messages needed to be customized to
address contextual differences and variations in prevention
needs, such as local context, demographic contexts, risk group,
or relationship contexts. For the written messages, 18 in-depth
interviews were conducted, two per risk group per study city.
Participants completed a ranking activity in which they were
given cards on which predeveloped written messages were
printed. Within each of the six domains listed above, participants
ranked the messages from most effective to least effective. They
were then asked about their reactions to each message, including
their comprehension, willingness to read the message,
appropriateness of the message and word choice, and their
perception of their ability to enact behavioral change. For the
video-based messages, 26 in-depth interviews were completed
across the study sites. Participants were shown each video-based
message and, after each, were asked about their reactions to the
videos, including identification of intended messages,
comprehension of the messages contained in each video, and
willingness to view the message. Participants were also asked
about specific elements of the video, such as length, style,
language use, and how each video might be made more
effective. Based on the feedback from participants in these focus
group discussions and in-depth interviews, each written and
video-based message was revised or edited by the subject matter
experts to be made more suitable for inclusion in the RCT.

Intervention Messaging
The M3 intervention provided risk-customized written and video
messages for participants, augmenting the core prevention
services available in HealthMindr. Core messages were
delivered to all participants regardless of HIV status and risk
group. Secondary messages were delivered to participants based
on their self-reported HIV status and risk group assignment at
baseline; risk group status was dynamic during the trial and
updated using data from monthly check-ins during the app
exposure period or by participant self-initiation of check-in.
Message domains for core and secondary messages are
summarized in Table 1. Video messages were 60-80 second
excerpts from existing videos related to HIV prevention and
education. A total of 12 video messages were offered as part of
the intervention for all participants regardless of risk group.

Table 1. M3 domains in the mobile app.
Domain

a

Core messages

Secondary messages

All risk groups

Lower risk HIV-negative

Higher risk HIV-negative

Condoms

✓

✓

✓

STIa testing

✓

✓

✓

HIV testing

✓

✓

✓

PrEPb

✓

ARTc

✓

✓

Engagement in care

✓

✓

HIV-positive

✓

✓

STI: sexually transmitted infection.

b

PrEP: pre-exposure prophylaxis.

c

ART: antiretroviral therapy.
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Messages were provided to participants according to a
predetermined schedule and in a consistent sequence that started
on their date of enrollment. Most messages provided a hyperlink
to relevant services referenced in the message. For example, a
message to promote routine HIV screening was paired with a
link to the app function for scheduling routine HIV screening
(Figure 2).

Commodity Ordering
Participants assigned to the intervention group also had the
ability to order prevention commodities (HIV at-home self-test
kits, home specimen collection kits for STI testing, condom
variety packages, and condom-compatible lubricant) directly
through the app for delivery to an address of their choosing.
The kits were purchased or built by Emory University, and
delivered through Amazon Fulfillment Services. At-home HIV
self-test kits were fulfilled with OraQuick kits (Orasure
Technologies, Bethlehem, Pennsylvania, United States).
At-home specimen collection kits (CareKits) were provided
through the Emory Center for AIDS Research, and included
instructions and materials for participants to collect urine, a
rectal swab, a pharyngeal swab, and microtainer blood
specimens sufficient to support testing for urethral, rectal, and
pharyngeal gonorrhea and chlamydia, and for syphilis.
Specimens were returned to the study laboratory by mail, and
STI testing was performed in a Clinical Laboratory Improvement
Amendments–certified laboratory using methods previously
reported [25]. Negative STI results were provided to participants
through emails or text messages; positive STI results were
provided to participants by phone call with referrals to treatment.
Positive STI test results were reported to state and local health
departments, as required by law and as disclosed to participants
during the informed consent process; HIV self-tests are sent by
participants directly to the vendor and thus HIV self-test results
during the study were unknown to staff.

Sullivan et al

Phase 2: Randomized Controlled Trial
A total of 1229 MSM were recruited and enrolled into a
randomized controlled trial in three US cities with substantial
HIV incidence: Detroit, Michigan; New York City, New York;
and Atlanta, Georgia [26]. The intervention of HIV prevention
messages and HealthMindr services were delivered as a mobile
phone app, available on both iOS and Android operating
systems. At the time of randomization, all participants received
standard of care referrals to HIV prevention and treatment
services in the form of a paper list of local prevention resources.

Study Design and Procedures
Overview
Among the 1229 men enrolled, 478 were from Atlanta, 335
from Detroit, and 416 from New York City. Men were randomly
assigned to either the immediate intervention group or the
waitlist-control group at a 1:1 ratio. All participants received
the same surveys at baseline and at three-month intervals
thereafter. At baseline, participants assigned to the intervention
group installed the M3 app and study staff gave them an
orientation on its use. These participants received access to the
full mobile app and messages based on their risk profiles over
a period of three months, after which the app was deactivated.
Wait-list control participants were not provided access to the
intervention app at the baseline visit but continued to receive
quarterly surveys. At nine months postenrollment, participants
in the waitlist-control group were given the option of accessing
the intervention app. Those who opted to do so were given the
app for three months and were asked to complete one final study
visit and survey at the 12-month point. Figure 2 provides an
overview of the study timeline and includes study visits,
procedures, and the participants involved at each time point.

Figure 2. Example text-based messages from the M3 app.
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Recruitment

Follow-Up Assessments

Recruitment activities were conducted over the course of 10
months in each study city from January-October 2018. To reflect
the diversity of MSM, we used a multi-modal recruitment
strategy with a goal of recruiting a sample of MSM who were
diverse in terms of age, race/ethnicity, and HIV risk. Modes of
recruitment included targeted banner advertisements (eg,
Facebook), traditional print advertisements (eg, flyers, public
transit), recruitment at venues, referrals from community service
providers, and in-person outreach.

To understand the effects of the intervention, follow-up surveys
were administered to all participants in three-month intervals
(a survey immediately postintervention, a three-month
postintervention follow-up, and a six-month postintervention
follow-up). The content of the postintervention surveys included
study outcomes, which included sexual risk behaviors and use
of prevention services. Participants took interim follow-up
assessment remotely at 3 and 6 months and were given the
option of taking the final 9-month outcome assessment remotely
or in person as the baseline was done.

Eligibility
Men eligible to participate in this study were: (1) aged 18 years
and older; (2) assigned a male sex at birth; (3) self-reported
their current gender identity as male; (4) self-reported anal
intercourse with a man in the past year; (5) were current
residents of the study city metropolitan area (Atlanta, Detroit,
or New York City); (6) planned to stay in the city area for the
next nine months; (7) owned and used an Android or iOS
smartphone; (8) were able to read and understand English
without assistance; and (9) were included in one of the three
groups of serostatus and risk groups described above. As of
November 2018, all study participants provided written informed
consent prior to participating in the study.

Enrollment
Men recruited in community venues were offered a brief
interviewer-administered screening survey; men recruited
through flyers or online venues were offered a brief online
eligibility screener. Eligible men were invited to attend an
in-person baseline enrollment visit. At the enrollment visit,
research staff reviewed consent documentation with potential
participants and reconfirmed eligibility criteria. Following
consent and enrollment, all participants completed a baseline
behavioral survey (see Multimedia Appendix 1) that collected
information related to primary and secondary outcomes,
including: (1) demographic characteristics; (2) HIV and STI
status and testing history; (3) condom use; (4) PrEP use and
adherence (for HIV-negative participants); (5) ART use and
adherence (for HIV-positive participants); (6) knowledge,
perceptions, beliefs, intents, and communication with sex
partners about HIV status and risk reduction; (7) mobile phone
and data usage; (8) access to Internet and information; and (9)
psychosocial covariates. The initial visit took up to 90 minutes.

Randomization
Following completion of the behavioral survey, participants
were randomized into either the intervention or the wait-list
control group. Participants were successfully randomized within
18 strata based on the three serostatus/risk groups, three cities,
and race/ethnicity (non-Hispanic white or not), ensuring balance
in randomization for these three dimensions [27]. Within the
strata of city, serostatus/risk group, and race/ethnicity,
participants were randomly assigned to the next treatment
allocation from a randomly permuted block sequence (block
sizes were 2 and 4).
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Incentives
Modest incentives were given to participants for completing
assessments in the study. Participants in the intervention group
could be compensated up to US $140 when completing all
assessments over the nine-month study period. Participants in
the waitlist-control group were compensated up to US $190
when opting to use the intervention app after nine months, and
US $140 if they chose not to use the intervention app. All
consenting participants who completed in-person site visits,
baseline visits, and nine-month follow-up were compensated
US $50, and an additional US $20 for each remotely completed
follow-up survey (immediately postintervention, after three
months, and after six months). Waitlist-control participants who
opted to use the intervention app were eligible for an additional
US $50 postintervention follow-up assessment incentive.

Measures
Serostatus-Specific Measures
HIV-Negative Participants
For HIV-negative participants, HIV testing was assessed at
baseline using a series of questions about HIV screening in the
previous 12-month and three-month intervals, including reasons
for screening behavior. Follow-up surveys asked about HIV
screening behaviors in the past three months. HIV-negative
participants were also asked a series of questions related to
PrEP, including if they were aware of PrEP, had ever used PrEP,
were currently using PrEP, or had discontinued PrEP. Reasons
for use or nonuse of PrEP were also included at baseline and in
three-month follow-up intervals. HIV-negative participants were
also asked about the likelihood of using possible PrEP agents
in the future. Additionally, participants were asked to rank their
prevention preferences when considering PrEP options that
might be available as future PrEP formulations.
HIV-Positive Participants
Participants living with HIV were asked at baseline about their
previous 12 months of engagement with HIV care, and at
follow-up about their previous 3 months of engagement with
HIV care. Questions included missed appointments, reasons for
nonengagement, and measures of viral suppression. Participants
living with HIV were also asked at baseline about their use of
ART in the previous 12-month period and previous 30-day
adherence. Postintervention surveys asked about previous
three-month initiation of ART and past 30-day adherence to
ART, if applicable. Questions also included reasons for missed
doses as well as the HIV Self-Efficacy Adherence Scale [28].
JMIR Res Protoc 2019 | vol. 8 | iss. 11 | e16439 | p. 6
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Questions Asked of All Participants
STI testing was assessed at baseline by asking participants if
they had been screened in the previous 12-month period for
non-HIV STIs, reasons for screening behavior, and any
STI-related vaccinations. STIs for analysis included chlamydia,
gonorrhea, syphilis, herpes, genital warts, hepatitis A, B, and
C, and any other STI. Follow-up surveys asked information
about screening and diagnoses in the previous three months.
All participants were asked at baseline and in follow-up surveys
about their recent experiences in accessing health care. All
participants were asked about their beliefs on the efficacy of
various HIV prevention methods (eg, condoms, PrEP) as well
as the likelihood they would engage in HIV prevention behaviors
in the next three-month period. All participants were asked
about sexual behaviors in the previous three-month period at
baseline and during three-month follow up surveys. Questions
delineated main from casual partners, enumerating casual
partners, and determining patterns of behavior for ongoing risk
group classification. Participants were asked at baseline and in
all postintervention surveys about substance use and
dependency. Alcohol misuse was assessed using the validated
Alcohol Use Disorders Identification Test (AUDIT) [29].
Participants were also asked which, if any, substances other
than alcohol they used. Substance dependency was assessed
with the Drug Use Dependency Identification Test (DUDIT)
[30].

Covariates
Factors that might be associated with intervention efficacy were
assessed at baseline and at three-month intervals. These included
the Centers for Epidemiological Studies on Depression 10-item
(CESD-10) scale [31] for past-week depressive symptoms, a
modified technology use scale from a 2015 Pew report [32],
lifetime and previous three-month sex work, previous

three-month intimate partner violence (IPV), previous-month
resilience, a subset of items from the HIV-related Stigma Scale,
a modified HIV/AIDS Conspiracy Scale [33], Perceived HIV
Severity Scale [34], and Health Care Mistrust Scale [35].

Data Analysis Plan
We will conduct bivariate analyses, stratified by intervention
group, for characteristics related to demographic factors,
educational history, social determinants of health, city of
enrollment, risk group, and baseline behaviors, to assess for
failure of randomization. Failure of randomization will be
defined by a significant (P<.05) difference in the distribution
of a characteristic between the intervention and control groups.
The primary outcomes of interest in this study (Table 2) will
be associated with the following alternative hypotheses:
assignment to the intervention group will be associated with
increased HIV testing among HIV-negative men, increased
engagement with HIV care and ART use/adherence among
people living with HIV, increased uptake and adherence to PrEP
among higher risk HIV-negative men, sustained lack of
condomless anal sex among lower risk HIV-negative men,
increased condom use for those who reported prior condomless
sex, and increased STI testing for all sexually active men.
Assuming that there are no failures of randomization, we will
use descriptive analyses to calculate the ratios of rates or
prevalence between participants assigned to the intervention
group and participants assigned to the control group. For HIV
testing, PrEP uptake, and STI testing, we will consider using
descriptive methods for time-to-event analysis and describing
unadjusted hazard ratios if randomization does not fail. If a
failure of randomization occurs, we will conduct a stratified
analysis for the association between outcomes and
randomization assignment by variable where the failure occurred
and will consider adjusting estimates for that factor if indicated.

Table 2. Primary outcomes.
Outcome

Participant HIV risk group
Lower risk and higher risk HIV-negative

HIV testing

✓

Engagement in HIV preventative care

✓

PrEPa uptake

✓

PrEP adherence

✓

Engagement in HIV care

✓

ARTb uptake

✓

ART adherence

✓

Condom use

✓

✓

Condom use compliance

✓

✓

✓

✓

c

STI testing
a

HIV-positive

PrEP: pre-exposure prophylaxis.

b

ART: antiretroviral therapy.

c

STI: sexually transmitted infection.
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Secondary outcomes will focus on participants’ self-reported
intentions, such as increasing the frequency of preventive
behaviors, decreasing risk behavior, seeking information and
treatment, and partner communication, particularly around risk
and prevention behaviors such as ART and PrEP. Secondary
outcome analysis will include intervention and control group
comparisons, similar to primary outcome analysis.

Human Subjects
Study procedures and documents, including consent forms,
eligibility screeners, assessments, recruitment advertisements,
and sexual health messages, were submitted and approved by
Emory University’s Institutional Review Board. All study staff
were required to complete training in human subjects research
ethics and data security before they were permitted to engage
in research procedures and view participant identification
information. Any third parties contracted in the data collection
and management process have established Business Associates
Agreements with Emory University, to ensure their adherence
to the scientific and ethical standards of the university. A data
safety monitoring board was not required for this study, as it
poses no greater than minimal risk due to the limited safety
concerns to the study population.
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prevention interventions, and could provide an opportunity to
reach men who might be geographically less accessible for
existing, in-person prevention services. The inclusion of mail-out
condoms and STI and HIV testing commodities also facilitates
the provision of a full package of basic services to rural MSM,
who are a group that are consistently less served with basic
sexual health services and commodities than urban MSM [37].
A further potential benefit of this approach is the HIV
serostatus-inclusiveness of the intervention: all men can
potentially benefit from the M3 app, regardless of HIV
serostatus.

Eisinger and Fauci have recently written that we have the tools
to end the HIV/AIDS pandemic, and that the remaining
challenge is to aggressively implement the effective strategies
that we have [36]. We agree and believe that the same premise
applies to HIV prevention: that prevention tools, including HIV
testing, condoms, STI testing, PrEP, and postexposure
prophylaxis, offer significant promise to curb new infections
among MSM if deployed at scale and aligned with the needs of
MSM. Here, we describe an RCT to test the effects of a mobile
phone app to help MSM select, coordinate, and manage their
use of prevention tools. The design incorporates both the
previously described HealthMindr app and a set of text and
video messages that are tailored to the HIV status and the risk
level of participants.

Our study is subject to a number of possible limitations, typical
of the potential biases associated with randomized prevention
trials [38]. It is possible that we might have selection bias,
manifested as a failure of randomization. We have taken steps
to mitigate this possibility by implementing stratified
randomization by site and risk group; stratified randomization
minimizes the risk for failure of randomization across a domain
that might be associated with efficacy. We will assess failure
of randomization by comparing the distribution of key
participant characteristics by randomization arm, using
chi-square or Fisher exact tests as appropriate. We anticipate
that there could be measurement bias because we are relying
on self-reported outcomes, as is common in behavioral studies.
We have attempted to minimize this bias by allowing options
for completing assessments privately or remotely, by using
previously established or validated items, and by measuring
key outcomes with multiple measures (for example, adherence
is assessed in both 7-day and 30-day recall periods, and assesses
condom use in the past 3 months and at last sexual encounter).
We could be subject to exclusion bias if there is differential loss
to follow-up between the intervention and control arms. We
mitigated this risk by using proven approaches to increase
retention in both arms, including multiple modes of contact
(phone, email, text message) and offering flexible options for
completing surveys at home or in the research clinic. Because
we set quotas to ensure adequate representation of men of color
and high- and low-risk HIV-negative men, our sample may not
have high external generalizability; however, we have designed
the study to have power to analyze within specific, high-priority
groups of participants, given their importance in HIV epidemics
among MSM living in the United States. Because of the
recruitment structure, cross-sectional analyses of the levels of
prevention and risk behaviors from the baseline data should be
interpreted in light of the sampling strategy.

The resulting M3 mobile app provides tailored electronic
messages along with service offerings in a unified platform,
potentially increasing the uptake of primary prevention
interventions. It features several characteristics of best practice
in the development of mHealth tools: it is theoretically
grounded, was developed through an iterative process with input
from likely end users and current prevention providers, and uses
tailoring of content based on the specific needs and
circumstances of users. If assignment to the intervention is
associated with higher use of prevention services, the M3 app
could be used by public health agencies to reach MSM with a
consistent, epidemiologically tailored package of HIV

Future study activities include completion of data collection for
the RCT, analysis of RCT data, and identification of possible
areas of improvement of the app for usability, including the
assessment of use patterns of waitlist-control participants. In
parallel, it is important that conversations with possible
implementers of electronic health interventions (eg, local and
state health departments and community-based prevention
organizations) continue to anticipate possible implementation
strategies and opportunities based on the principles of
implementation science, in case the results of the RCT indicate
improved outcomes for men randomized to the intervention
group [39].

Results
M3 enrollment began in January 2018 and concluded in
November 2018. A total of 1229 MSM were enrolled. Data
collection was completed in September 2019.

Discussion
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